Kite Pharma

YESCARTA - Cost

Last Updated: April 1st, 2024

HCPCS:

Q2041

HCPCS Code Descriptor:

Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Medicare Payment Limit:

The YESCARTA Medicare Payment Limit is $459381.446

Average Sale Price:

YESCARTA ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The YESCARTA Medicare Co-insurance percentage is 20%. YESCARTA's Medicare Co-insurance amount is $91876.29 per HCPCS unit.

APC Code:

The Yescarta APC Code is: 9035

APC Payment Limit:

The APC Payment Limit for YESCARTA is available. Login to view.

Yescarta Cost Information:

YESCARTA is manufactured by Kite Pharma and became effective on January 1, 2019. YESCARTA is aligned to HCPCS Q2041. From 2019 through early 2021, prices remained constant. Towards the middle of 2021, prices began an upward trend increasing by nearly 25% through 2024.

ACCESS PRICING AND MORE BY REGISTERING

Yescarta’s wholesale acquisition cost (WAC) information was last updated on:
November 3, 2023
Yescarta’s average wholesale price (AWP) information was last updated on:
November 3, 2023

Yescarta Cost Graph: